References
Schlesselman JJ. Case control studies. Oxford: Oxford University Press; 1982.
MacMahon B, Yen S, Trichopoulos D, Warren K, Nardi G. Coffee and cancer of the pancreas. New Engl J Med. 1981;304:630–3.
Bracken MB. Risk, chance and causation: investigating the origins and treatment of disease. New Haven: Yale University Press; 2013.
Bracken MB. Methodological issues in the epidemiologic investigation of drug-induced congenital malformations. In: Bracken MB, editor. Perinatal epidemiology. Oxford: Oxford University Press; 1984.
Bracken MB, Holford TR, White C, Kelsey JL. Role of oral contraception in congenital malformations of offspring. Int J Epidemiol. 1978;7:309–17.
Reefhuis J, Devine O, Friedman JM, Louik C, Honein MA. National birth defects prevention study. Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports. BMJ. 2015;350:h3190.
Wemakor A, Casson K, Garne E, Bakker M, Addor MC, Arriola L, Gatt M, Khoshnood B, Klungsoyr K, Nelen V, O’Mahoney M, Pierini A, Rissmann A, Tucker D, Boyle B, de Jong-van den Berg L, Dolk H. Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study. Eur J Epidemiol. 2015. doi:10.1007/s10654-015-0065-y.
Furu K, Kieler H, Haglund B, Engeland A, Selmer R, Stephansson O, Valdimarsdottir UA, Zoega H, Artama M, Gissler M, Malm H, Nørgaard M. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. BMJ. 2015;350:h1798.
Ban L, Gibson JE, West J, Fiaschi L, Sokal R, Smeeth L, Doyle P, Hubbard RB, Tata LJ. Maternal depression, antidepressant prescriptions, and congenital malformation risk in offspring: a population based cohort study. BJOG. 2014;121:1471–81.
Nordeng H, van Gelder MM, Spigset O, Koren G, Einarson A, Eberhard-Gran M. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian mother and child cohort study. J Clin Psychopharm. 2012;32:186–94.
Huybrechts KF, Palmsten K, Avorn J, Cohen LS, Holmes LB, Franklin JM, Mogun H, Levin R, Kowal M, Setoguchi S, Hernández-Díaz S. Antidepressant use in pregnancy and the risk of cardiac defects. New Engl J Med. 2014;370:2397–407.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Professor Bracken is a consultant and expert witness for Glaxo-Smith-Kline Pharmaceuticals and Forest Research Laboratories, both manufacturers of SSRIs.
Rights and permissions
About this article
Cite this article
Bracken, M.B. Case–control studies require appropriate population controls: an example of error in the SSRI birth defect literature. Eur J Epidemiol 30, 1217–1218 (2015). https://doi.org/10.1007/s10654-015-0097-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-015-0097-3